PubMed Health⌕ Search

PubMed · 15015125

Polymer depletion interaction between parallel walls--a Monte Carlo study.

Abstract

An off-lattice bead-spring model of self-assembling equilibrium ("living") polymers is used to study the polymer-induced interaction between parallel walls immersed in polydisperse solutions of different concentration by means of Monte Carlo simulation. The two walls form an open slit in contact with an external reservoir so that the confined system may exchange monomers with the surrounding phase and adapt its polydispersity in order to relax the confinement constraint. We find that the properties of the polymers in the constrained system as well as the net force deltaF acting on the walls depend essentially on the polymer concentration in the reservoir which leads to qualitative differences in their behavior with changing inter-planar distance H: In a dilute polymer solution at concentration phi below the semi-dilute threshold phi* the force between the walls is attractive and decreases steadily with growing wall separation H, so that deltaF approximately 0 at H/ Rg> or =3 if H is measured in gyration radii Rg of the unperturbed polymers. The total monomer concentration within the slit is smaller than the concentration in the reservoir and decreases monotonically with H/Rg-->0. The ratio Nin/Nout of mean chain length Nin in the slit to that in the reservoir, Nout, decreases from unity at H-->infinity, goes through a minimum at H/Rg approximately 1, and then rises again to Nin/Nout>1 for wall separations H/Rg<1. In contrast, in a dense solution of equilibrium polymers at phi>phi* one detects no indirect wall-wall interaction, deltaF approximately 0, for H larger than the monomer size. Thus, earlier speculations about the existence of possible depletion interaction between parallel walls even in a dense polymer system cannot be confirmed. Inside the slit the monomer density is found to be always larger than in the reservoir while Nin/Nout<1 and decreases steadily as H/Rg-->0. The depletion force between parallel plates has been determined also in a monodisperse solution of conventional polymers. Qualitatively the force behavior does not differ from that of living polymers.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Milchev. 2002. Polymer depletion interaction between parallel walls--a Monte Carlo study.. https://doi.org/10.1140/epje%2Fi2002-10041-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗